Literature DB >> 6256527

Maturation of sympathetic neurotransmission in the rat heart. VII. Suppression of sympathetic responses by dexamethasone.

C Lau, T A Slotkin.   

Abstract

Effects of dexamethasone on development of sympathetic nerve function in the heart were evaluated by giving 1 mg/kg of dexamethasone s.c. daily for several days beginning the day after birth. Dexamethasone interfered with tyramine- and isoproterenol-induced tachycardia in the neonates but did not cause alterations in development of a marker for presynaptic sympathetic nerve terminals (synaptic vesicle uptake of [3H] norepinephrine) nor of postsynaptic beta adrenoceptor binding of [3H]dihydroalprenolol; the deficit was also unrelated to general cellular effects of the hormone. These data suggest that the subnormal chronotropic responses of the heart to sympathetic stimulation in dexamethasone-treated neonatal rats result from uncoupling of receptors from the organ response. The effects of dexamethasone on cardiac responses were specific to the neonate, as mature rats given dexamethasone did not show suppression of cardiac sympathetic action. Neonatal dexamethasone treatment also produced a deficit of adrenomedullary development with deficiencies in catecholamine levels and in catecholamine biosynthetic enzymes; deficits in phenylethanolamine N-methyltransferase activity persisted into young adulthood.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6256527

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Fetal cardiovascular, metabolic and endocrine responses to acute hypoxaemia during and following maternal treatment with dexamethasone in sheep.

Authors:  J K Jellyman; D S Gardner; C M B Edwards; A L Fowden; D A Giussani
Journal:  J Physiol       Date:  2005-06-23       Impact factor: 5.182

2.  Developmental neurotoxicity targeting hepatic and cardiac sympathetic innervation: effects of organophosphates are distinct from those of glucocorticoids.

Authors:  Frederic J Seidler; Theodore A Slotkin
Journal:  Brain Res Bull       Date:  2011-03-29       Impact factor: 4.077

3.  Cardiovascular and endocrine responses to acute hypoxaemia during and following dexamethasone infusion in the ovine fetus.

Authors:  Andrew J W Fletcher; David S Gardner; C Mark B Edwards; Abigail L Fowden; Dino A Giussani
Journal:  J Physiol       Date:  2003-03-28       Impact factor: 5.182

4.  Effects of gestational age and cortisol treatment on ovine fetal heart function in a novel biventricular Langendorff preparation.

Authors:  Andrew J W Fletcher; Alison J Forhead; Abigail L Fowden; Will R Ford; Peter W Nathanielsz; Dino A Giussani
Journal:  J Physiol       Date:  2004-10-28       Impact factor: 5.182

5.  Neonatal dexamethasone treatment leads to alterations in cell signaling cascades controlling hepatic and cardiac function in adulthood.

Authors:  Abayomi A Adigun; Nicola Wrench; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-10-20       Impact factor: 3.763

6.  Does growth impairment underlie the adverse effects of dexamethasone on development of noradrenergic systems?

Authors:  Theodore A Slotkin; Ashley Ko; Frederic J Seidler
Journal:  Toxicology       Date:  2018-06-20       Impact factor: 4.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.